-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Basal forebrain (BF) In neurodegenerative diseases, BF cholinergic neurons often degenerate, leading to subsequent cognitive decline
β-Amyloid BF atrophy α-synuclein cholinergic deficiency Since cortical atrophy can reflect the pathological spreading pattern of AD and LBD, a comparative assessment of cortical thinning patterns associated with cholinergic atrophy and β-amyloid burden has Helps understand the two most common neurodegenerative diseases
18F -flubetabine positron emission tomography with BF volume and cortical thickness (CTH) and β-amyloid load obtained by magnetic resonance imaging (MRI), neuropsychological assessment of cognitive function.
18 Hypertension Diabetes
- BF volume mediates the association of FBB-SUVR with cortical thickness in AD and LBD disease spectrum, whereas FBB-SUVR is associated with CTH independently of BF volume only in LBD disease spectrum
There are common β-amyloidosis mechanisms in AD and LBD spectrum, with or without BF mediation, BF atrophy is more profoundly related to cognitive impairment, and localized β-amyloid is present in LBD disease spectrum and cortical atrophy
Yoo HS, Jeon S, Cavedo E, et al.
Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra [published online ahead of print, 2021 Dec 30].
Neurology.
2021;10.
1212/ WNL.
0000000000013277.
doi:10.
1212/WNL.
0000000000013277Leave
a message here